MedCity News

Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care

Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases

Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing.

By Frank Vinluan

Devices & Diagnostics, Startups, Health Tech, Providers

Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits

A recent JAMA editorial from two radiologists argues that elective whole-body MRI scan companies are misleading consumers about the benefits of said scans. The radiologists argue the MRIs are more likely to trigger harmful downstream procedures than they are to save lives. Not surprisingly, the three most prominent companies offering these scans denied the charge.

By Katie Adams

Latest Video

Latest News

MedCity Influencers

Financial investment management or wealth management. Isometric merchants conducting business activities

What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures

These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road.

By Destiny Flood and Richard L. Weiner

MedCity Influencers

A human hand interacts with an artificial intelligence robotic hand with medical icons and a digital interface on dark background, illustrating healthcare technology AI trust

Beyond the Pilot Trap: How Healthcare Can Scale AI Without Losing Trust

The future of healthcare depends on enterprises moving decisively beyond the pilot trap by treating enterprise AI as a platform capable of sustaining hundreds of dynamic models.

By Prashant Sareen

MedCity Influencers

AI Won’t Fix Physician Burnout — Giving Them More Autonomy Will

AI documentation tools are genuinely useful. But they are treating a symptom, not the disease. The disease is that physicians have lost control over how they work.

By Dr. Marc Ayoub

Health Tech, Payers, Providers

What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle?

AI hasn't solved all the problems plaguing healthcare's revenue cycle — but R1's Lee Kupferman says that it is getting closer, one gray area at a time.

By Katie Adams

Payers

KFF: Insurer Participation in ACA Marketplaces Is Down

KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025.

By Marissa Plescia

BioPharma, Legal

FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility

UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the FDA’s reversal of its prior position calling for another clinical trial. This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging back to regulatory flexibility.

By Frank Vinluan

MedCity Influencers

Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards

Combined upper and lower GI endoscopy is becoming standard practice across many US healthcare settings, but the quality infrastructure for upper GI has not kept pace with the procedures now being performed on it.

By Dror Zur

MedCity Influencers

The Human Behind the Machine: Why Healthcare Must Resist the Rush To Automate

The healthcare organizations getting this right are not defined by how much they’ve automated. They are defined by how deliberately they’ve protected the human touchpoints that drive trust, engagement, and outcomes.

By Michael Oleksiw

MedCity Influencers

Hand arranging wood block stacking with icon internal organs

Leveraging Technology to Navigate the New Era of Continuous Organ Distribution

As air transportation for organs becomes more common, both in response to tech advancements and changing federal guidelines, the industry needs tools that synchronize communication between dispersed teams and can keep pace with air transport.

By Lisa Anderson

Health Tech

InStride Raises $30M to Scale Pediatric Mental Health Support

InStride's Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures.

By Marissa Plescia

BioPharma, Startups

New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug

MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma.

By Frank Vinluan

Devices & Diagnostics

Extremely enthusiastic sports fan with team flag makes face of disbelief and shouts with other fans standing in crowded stadium bleachers after their favorite football team scores a goal in a competitive world sports championship

What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak

Verily is testing wastewater across World Cup host cities for pathogens like RSV, measles and norovirus, aiming to spot outbreaks five to seven days before they show up in clinics.

By Katie Adams

MedCity Influencers

The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design

New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial designs and the complexities of diseases such as certain cancers and rare disorders, which may lead to more efficient trials, lower development costs, and faster innovation.

By Stacy R. Lindborg

MedCity Influencers

Paper Craft of the Final Piece to Solving a Jigsaw Puzzle on Blue Background Directly Above View.

Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation

Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other component of care delivery. That requires these three things.

By Sufian Chowdhury

MedCity Influencers

Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare

The autonomous healthcare system is about to take shape, and health systems must prepare to evolve alongside it.

By David W. Johnson